openPR Logo
Press release

Tracheobronchial Stent Grafts Market Scope and Trends Report 2027

08-10-2017 03:38 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Tracheobronchial Stent Grafts Market Scope and Trends Report

Tracheobronchial stent grafts are used in management of lumen collapse or to prevent collapse after tracheobronchial reconstruction procedure, after trauma or lesions, airway obstruction etc. tracheobronchial stent-graft is a self-expanding stent generally made of nitinol mesh wire and encapsulated within two ultra-thin layers of expanded polytetrafluoroethylene (ePTFE). Moreover, number of benign and malignant conditions can cause tracheobronchial narrowing or collapse which can lead to symptomatic and life-threatening dyspnea. Tracheobronchial stent graft system is mainly approved for use in treatment of in-stent restenosis in venous outflow in hemodialysis patients. The first tracheobronchial stent graft system ‘Fluency’ was introduced in 2003 by C.R. Bard Inc. In 2005, W. L. Gore & Associates launched VIABAHN in the U.S. for use in treatment of tracheobronchial strictures. Both of these systems witnessed positive response from physicians and patients. Now-a-days, these devices are available in ling delivery sheaths or catheters necessary for placement of tracheobronchial stent graft.

Read the Comprehensive Overview of Tracheobronchial Stent Grafts Market: http://www.transparencymarketresearch.com/tracheobronchial-stent-grafts-market.html

Tracheobronchial Stent Grafts Market: Drivers and Restraints

Increasing prevalence of chronic lung disorders such as tuberculosis and benign or malignant tumors are the foremost factor driving the growth of global tracheobronchial stent grafts market over the forecast period. Besides, easy and efficient procedure is the other factor expected to flourish the global tracheobronchial stent grafts market However, limited product approvals for tracheobronchial stent grafts in Europe. And alternative treatment options for tracheobronchial strictures are the important factors limiting the growth of global tracheobronchial stent grafts market.

Tracheobronchial Stent Grafts Market: Segmentation

Tentatively, global tracheobronchial stent grafts market has been segmented on the basis of end user, and geography.

Based on end user, global tracheobronchial stent grafts market is segmented as below:

Hospitals
Ambulatory Surgical Centers

Tracheobronchial Stent Grafts Market: Overview

Recent approval of Fluency Plus brings new hope to patients suffering from chronic lung diseases that cause airway obstruction. These device is expected to gain rapid adoption by patients as it is minimally invasive procedure and involves less risk that other approaches used for management of tracheobronchial strictures. The global market for tracheobronchial stent grafts is expected to grow significantly with high single digit growth rate over the forecast period of 2017–2027.

Tracheobronchial Stent Grafts Market: Regional Outlook

Geographically, tracheobronchial stent grafts market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global tracheobronchial stent grafts market over the forecast period. Japan is expected to be the second largest market for tracheobronchial stent grafts. Despite the fact that tracheobronchial stent graft systems are being used since 2003, these systems are approved for clinical use only in the U.S., Canada and Japan. Key player in tracheobronchial stent grafts market is are trying to obtain regulatory approval in Europe in order to capture growing patient volume for chronic lung diseases.

Tracheobronchial Stent Grafts Market: Key Players

So far BARD Peripheral Vascular. Inc. – a subsidiary of C.R. Bard Inc., and W. L. Gore & Associates are the only player operating in the global market for tracheobronchial stent graft systems. Bard offers Fluency and Fluency Plus tracheobronchial stent grafts in North America and Japan. Some of the other systems such as Symbiot and Corvita Endoluminal Stent-Graft were being studied in the Europe but unfortunately they failed to meet required clinical end points and never came to market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25985

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tracheobronchial Stent Grafts Market Scope and Trends Report 2027 here

News-ID: 664734 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Tracheobronchial

Tracheobronchial Stents Market Competitive Landscape, Growth Factors, Revenue An …
The Tracheobronchial Stents Market size is expected to grow at an annual average of CAGR 7% during the forecast period (2023-2029). Medical devices have transformed a stent from being bare metallic mesh or a silicone tube to being biodegradable and custom made. Tracheobronchial stents are valuable adjuncts to the palliation of patients who suffer from central airway obstruction (CAO). Important changes in the business allow key players to attain larger profits.
Tracheobronchial Stents Market Overview, Demand, Supply and Production Status 20 …
In the past few years, the Tracheobronchial Stents Market experienced a huge change under the influence of COVID-19 and Russia-Ukraine War, the global market size of Well Plates reached million $ in 2022 from in 2017 with a CAGR of from 2017-2022. Facing the complicated international situation, the future of the market is full of uncertain. Bis Report predicts that the global market size will reach (2028 Market size) million
Tracheobronchial Stents Business Revenue Market Share in 2022- Boston Scientific …
The Tracheobronchial Stents Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients' live - be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality. According to the latest
Global Tracheobronchial Stents Market By End Users/Application Research Report 2 …
The Tracheobronchial Stents Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients' live - be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality. According to the latest
The Tracheobronchial Stent Grafts Market to Get Digitally Stabilized
The Tracheobronchial Stent Grafts Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to
Sales of Tracheobronchial Stent Grafts Market to Grow at Robust CAGR during 2020 …
Tracheobronchial stent grafts are used in management of lumen collapse or to prevent collapse after tracheobronchial reconstruction procedure, after trauma or lesions, airway obstruction etc. tracheobronchial stent-graft is a self-expanding stent generally made of nitinol mesh wire and encapsulated within two ultra-thin layers of expanded polytetrafluoroethylene (ePTFE). Moreover, number of benign and malignant conditions can cause tracheobronchial narrowing or collapse which can lead to symptomatic and life-threatening dyspnea. Tracheobronchial stent